Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adrenomedullin for Catheter Ablation in Persistent Atrial Fibrillation (AM-AF)
jRCTs071190005Completed
- Sponsor
- University of Miyazaki Hospital
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of fispemifene in Atrial fibrillation (AFib) (2 arms), sponsored by University of Miyazaki Hospital. Primary endpoint: Total time of significant atrial arrhythmias within 3 days after catheter ablation. Started Oct 2019; status: completed.
02
Drugs
fispemifene
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on jRCTs071190005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071190005.